Your browser is no longer supported. Please, upgrade your browser.
ANGO AngioDynamics, Inc. weekly Stock Chart
ANGO [NASD]
AngioDynamics, Inc.
Index- P/E179.69 EPS (ttm)0.10 Insider Own1.60% Shs Outstand36.92M Perf Week2.68%
Market Cap636.85M Forward P/E23.37 EPS next Y0.74 Insider Trans5.41% Shs Float36.38M Perf Month-3.95%
Income3.70M PEG12.88 EPS next Q0.16 Inst Own97.20% Short Float3.83% Perf Quarter14.09%
Sales347.00M P/S1.84 EPS this Y111.20% Inst Trans0.03% Short Ratio5.65 Perf Half Y12.01%
Book/sh14.03 P/B1.23 EPS next Y12.16% ROA0.50% Target Price17.67 Perf Year1.05%
Cash/sh1.34 P/C12.89 EPS next 5Y13.95% ROE0.70% 52W Range14.80 - 18.85 Perf YTD2.25%
Dividend- P/FCF12.41 EPS past 5Y21.60% ROI1.30% 52W High-8.49% Beta1.06
Dividend %- Quick Ratio1.50 Sales past 5Y9.50% Gross Margin49.70% 52W Low16.55% ATR0.47
Employees1250 Current Ratio2.30 Sales Q/Q-3.10% Oper. Margin2.70% RSI (14)50.88 Volatility1.86% 2.52%
OptionableYes Debt/Eq0.18 EPS Q/Q-102.70% Profit Margin1.10% Rel Volume1.00 Prev Close17.06
ShortableYes LT Debt/Eq0.17 EarningsOct 04 Payout0.00% Avg Volume247.06K Price17.25
Recom2.80 SMA20-0.44% SMA500.65% SMA2004.74% Volume246,985 Change1.11%
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-08-17Initiated Barclays Equal Weight $17
Nov-04-16Initiated Cantor Fitzgerald Buy
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Mar-04-10Initiated Wedbush Morgan Neutral $17.50
Sep-04-09Reiterated Caris & Company Above Average $13 → $15
Jul-17-09Reiterated Caris & Company Above Average $15 → $13
Jan-07-09Downgrade Caris & Company Buy → Above Average $20 → $15
Nov-13-08Initiated Stifel Nicolaus Hold
Oct-11-17 07:40AM  Earnings Review and Free Research Report: AngioDynamics Reported Lower than Expected Quarterly Results ACCESSWIRE
Oct-04-17 10:31AM  ETFs with exposure to AngioDynamics, Inc. : October 4, 2017 Capital Cube
08:51AM  AngioDynamicis' (ANGO) Solero MTA System to Drive Growth Zacks
07:00AM  Earnings Review and Free Research Report: Lakelands Revenue Jumped 7.4%; EPS Surged 25% ACCESSWIRE
Oct-03-17 09:43AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017 Capital Cube
07:00AM  Corporate News Blog - Skyline Medical Provides Update on Pending CytoBioscience Merger ACCESSWIRE
Oct-02-17 11:14AM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : October 2, 2017 Capital Cube
10:08AM  AngioDynamics (ANGO) Misses on Earnings & Revenues in Q1 Zacks
Sep-29-17 08:15AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : September 29, 2017 Capital Cube
Sep-28-17 09:41PM  AngioDynamics misses Street 1Q forecasts Associated Press -13.17%
06:00AM  AngioDynamics Reports Fiscal 2018 First Quarter Results GlobeNewswire
Sep-26-17 07:09AM  Can AngioDynamics (ANGO) Spring a Surprise in Q1 Earnings? Zacks
Sep-18-17 08:06AM  AngioDynamics' BioFlo Platform Strong, Debt Levels High Zacks
Sep-14-17 07:00AM  Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open GlobeNewswire
06:00AM  AngioDynamics to Report Fiscal 2018 First Quarter Financial Results GlobeNewswire
Sep-13-17 06:00AM  AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Aug-29-17 06:00AM  AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-18-17 04:20PM  ETFs with exposure to AngioDynamics, Inc. : August 18, 2017 Capital Cube
03:41AM  AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? Zacks
Aug-12-17 11:40PM  Edited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-08-17 09:52AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017 Capital Cube
Aug-07-17 07:49AM  AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-17 04:25PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
Jul-26-17 09:19AM  INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO PR Newswire
Jul-24-17 06:56PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire +7.35%
01:21PM  Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc. PR Newswire
Jul-21-17 05:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO Accesswire
Jul-19-17 09:08AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017 Capital Cube
09:08AM  AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat Zacks
Jul-18-17 06:23PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -6.78%
06:21PM  ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations Business Wire
05:43PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc. Business Wire
04:49PM  AngioDynamics reports 4Q loss Associated Press
03:28PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
02:32PM  ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm PR Newswire
02:11PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO) PR Newswire
01:05PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
12:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO PR Newswire
06:00AM  AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results GlobeNewswire
Jul-07-17 06:00AM  AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results GlobeNewswire
Jun-15-17 04:06PM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : June 15, 2017 Capital Cube
01:03PM  ETFs with exposure to AngioDynamics, Inc. : June 15, 2017 Capital Cube
Jun-14-17 08:20AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : June 14, 2017 Capital Cube
Jun-09-17 08:15AM  Featured Company News - Medical Devices Company AngioDynamics Receives FDA Clearance for Solero MTA System Accesswire
Jun-07-17 06:00AM  AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System GlobeNewswire
May-31-17 03:48PM  Albany public company files lawsuit alleging competitor violated antitrust laws American City Business Journals
06:00AM  AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access GlobeNewswire
May-09-17 06:00AM  AngioDynamics to Present at the 2017 UBS Global Healthcare Conference GlobeNewswire
May-01-17 03:11AM  AngioDynamics (ANGO) Down 11.7% Since Earnings Report: Can It Rebound? Zacks
Apr-20-17 06:00AM  AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference GlobeNewswire
Apr-10-17 10:06AM  AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering Zacks
08:32AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 10, 2017 Capital Cube
Apr-07-17 09:25AM  Endo international, AngioDynamics Lead Biotech Movers TheStreet.com
Apr-06-17 07:49PM  AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire
04:02PM  AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders GlobeNewswire
Apr-05-17 04:18PM  ETFs with exposure to AngioDynamics, Inc. : April 5, 2017 Capital Cube
Apr-04-17 05:54PM  5 Cheap Value Stocks to Tame a Capricious Market in Q2 Zacks
09:23AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2017 By the Numbers : April 4, 2017 Capital Cube
Apr-03-17 10:57AM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report
Mar-31-17 11:04AM  AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View Zacks
Mar-30-17 07:32PM  Edited Transcript of ANGO earnings conference call or presentation 30-Mar-17 12:00pm GMT Thomson Reuters StreetEvents
01:35PM  AngioDynamics downgraded by KeyBanc Capital Mkts
08:02AM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q3 2017 AngioDynamics Inc Earnings Release - Before Market Open
06:12AM  AngioDynamics tops 3Q profit forecasts Associated Press
06:00AM  AngioDynamics Reports Fiscal 2017 Third Quarter Results GlobeNewswire
Mar-29-17 10:45AM  Here's Why You Should Steer Clear of Mednax (MD) for Now
10:45AM  Here's Why You Should Steer Clear of Mednax (MD) for Now Investopedia
Mar-27-17 06:55AM  AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City GlobeNewswire
Mar-20-17 06:00AM  AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results GlobeNewswire
Mar-15-17 10:12AM  AngioDynamics Microwave Tissue Ablation System Now CE Marked
Mar-14-17 06:00AM  AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System GlobeNewswire
Mar-13-17 09:02AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 13, 2017
Mar-08-17 09:26AM  AngioDynamics to Present at the Barclays Global Healthcare Conference GlobeNewswire
Jan-20-17 08:32AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : January 20, 2017
Jan-19-17 12:13PM  ETFs with exposure to AngioDynamics, Inc. : January 19, 2017
Jan-17-17 08:14AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2017 By the Numbers : January 17, 2017
Jan-12-17 01:04PM  ANGIODYNAMICS INC Financials
Jan-11-17 08:15AM  Post Earnings Coverage as AngioDynamics Adjusted EPS Soared 36% Accesswire
Jan-10-17 11:18AM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-09-17 09:51AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
08:03AM  AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View
Jan-06-17 02:46PM  Edited Transcript of ANGO earnings conference call or presentation 6-Jan-17 1:00pm GMT
12:01PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
07:07AM  Q2 2017 AngioDynamics Inc Earnings Release - Before Market Open
06:08AM  AngioDynamics beats 2Q profit forecasts
06:00AM  AngioDynamics Reports Fiscal 2017 Second Quarter Results GlobeNewswire
Jan-03-17 06:00AM  AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-20-16 06:00AM  AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results GlobeNewswire
Dec-16-16 12:13AM  How Nantkwest Inc (NK) Stacks Up Versus Peers at Insider Monkey
Dec-09-16 11:09AM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : December 9, 2016
08:28AM  Is NeoGenomics, Inc. (NEO) A Good Stock To Buy? at Insider Monkey
Dec-08-16 01:14PM  Should You Follow the Smart Money Surge into AngioDynamics, Inc. (ANGO)? at Insider Monkey
07:20AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : December 8, 2016
Nov-29-16 03:30PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors Accesswire
Nov-28-16 11:31AM  ETFs with exposure to AngioDynamics, Inc. : November 28, 2016
09:30AM  Zacks.com featured highlights: First American Financial, AngioDynamics, Microsemi, Thermo Fisher Scientific and F5 Networks
06:00AM  AngioDynamics to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-25-16 07:05AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 25, 2016
Nov-18-16 04:09PM  ANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gould Kevin JDirectorSep 12Option Exercise14.0339,000547,17065,064Sep 14 03:24 PM
JOHNSON WESLEYDirectorJul 25Option Exercise15.7514,000220,50060,974Aug 08 05:48 PM
Meteny Dennis SDirectorJul 25Option Exercise15.7514,000220,50083,127Aug 08 05:44 PM
GOLD JEFFREYDirectorJul 25Option Exercise15.7514,000220,50066,037Jul 28 03:47 PM
REED JAN STERNDirectorJul 24Buy16.003165,056316Jul 25 02:33 PM
DONNELLY HOWARD WDirectorJul 21Buy15.725,00078,60047,600Jul 21 09:46 PM
Clemmer James CPresident and CEOJul 21Buy15.795,00078,95091,683Jul 21 06:43 PM
Clemmer James CPresident and CEOJul 20Buy15.6420,000312,80086,683Jul 21 06:43 PM
DONNELLY HOWARD WDirectorJun 19Option Exercise15.7514,000220,50056,144Jun 21 09:42 PM
Burgstahler David FDirectorApr 12Sale16.002,350,00037,600,000381,406Apr 14 04:48 PM
Avista Capital Partners GP, LL10% OwnerApr 12Sale16.002,350,00037,600,000381,406Apr 14 04:40 PM
LaPorte SteveDirectorJan 13Option Exercise15.7514,000220,50048,201Jan 17 02:34 PM
Avista Capital Partners GP, LL10% OwnerNov 18Sale15.682,091,29432,791,4901,014,058Nov 22 04:20 PM
Burgstahler David FDirectorNov 18Sale15.682,091,29432,791,4901,014,058Nov 22 04:21 PM